Work

Abstract 16421: Inhibition of Bone Morphogenetic Protein (BMP) Signaling Mitigates Nonalcoholic Fatty Liver Disease (NAFLD) and Identification of an Activating BMP Receptor Polymorphism Associated With NAFLD